Biotech

Startups News

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 10.05.2022.

Biotechnology
Medicine
Pharmaceutical drug
Professor
Lexus
Bristol-Myers Squibb

Startups

@ForbesTech shared
On May 9, 2022
AI 50 Methodology: How We Selected Our Honorees https://t.co/sYCAf09hqI https://t.co/Ntw3015waS
Open
AI 50 Methodology: How We Selected Our Honorees

AI 50 Methodology: How We Selected Our Honorees

More than 400 companies were considered for this year’s list. Finalists were selected based on their use of AI-enabled technology, business models and financials.

@matthewherper shared
On May 9, 2022
RT @BentheFidler: Clay Siegall, founding CEO of SeaGen, takes leave amid domestic violence accusation https://t.co/kOcHQSHqBx $SGEN
Open
Clay Siegall, founding Seagen CEO, takes leave amid domestic violence accusation

Clay Siegall, founding Seagen CEO, takes leave amid domestic violence accusation

The company's board is investigating the allegation, which Siegall, who has led Seattle's largest biotech for 24 years, denied. Chief Medical Officer Roger Dansey, a former Merck & Co. ...

@ReutersBiz shared
On May 10, 2022
Japan's Opn raises $120 million, becomes rare unicorn https://t.co/WZF7qdciXz https://t.co/HcUvQ1wNkQ
Open
Japan's Opn raises $120 million, becomes rare unicorn

Japan's Opn raises $120 million, becomes rare unicorn

Digital payments processor Opn, formerly known as Synqa, said it had raised $120 million in a Series C+ funding round, becoming a rare unicorn, or startup worth more than $1 billion, in ...

@BentheFidler shared
On May 4, 2022
Moderna vaccine sales surpass expectations as company looks to fall boosters https://t.co/UkkzaIVewR by @NedPagliarulo $MRNA $PFE #COVID19
Open
Moderna vaccine sales surpass expectations as company looks to fall boosters

Moderna vaccine sales surpass expectations as company looks to fall boosters

The trajectory of COVID-19 vaccine sales is now harder to predict amid questions about the rollout of additional doses and whether purchasing in the U.S. might shift from the federal ...

@GENbio shared
On May 9, 2022
RT @Inside_PM: Jonas Korlach, @PacBio CSO and co-inventor of its revolutionary single-molecule real-time sequencing technology, discusses the development of PacBio and HiFi sequencing and the long-awaited completion of the human genome project. Read more: https://t.co/LiorGar9Q2 https://t.co/aIQrcjO6dM
Open
The Human Genome: Finished with High Fidelity

The Human Genome: Finished with High Fidelity

Jonas Korlach, PacBio CSO and co-inventor of its revolutionary single-molecule real-time sequencing technology, discusses the development of PacBio and HiFi sequencing and the long-awaited ...

@bijans shared
On May 9, 2022
RT @boltyboy: While #JeffGoldsmith & #EricLarsen's piece on @THCBstaff called "The Reckoning: What Happens to Digital Health After COVID?" discusses long term scenarios, the #DigitalHealth stocks continue to get killed. Off way more than the Nasdaq https://t.co/gXmhO4i9Ya https://t.co/WwXqXOoWn6
Open
The Reckoning: What Happens to Digital Health After COVID?

The Reckoning: What Happens to Digital Health After COVID?

By JEFF GOLDSMITH and ERIC LARSEN It has been a rough year so far for digital health. After an astonishing $45 billion poured into new digital health companies in 2020 and 2021, and an ...

@BentheFidler shared
On May 6, 2022
Novartis suspends production of two radiopharmaceutical drugs over quality concerns https://t.co/u7b9ioljRN by @NedPagliarulo $NVS
Open
Novartis suspends production of two radiopharmaceutical drugs over quality concerns

Novartis suspends production of two radiopharmaceutical drugs over quality concerns

Due to potential issues in manufacturing, the pharma is halting deliveries of two cancer drugs, Lutathera and Pluvicto, in the U.S. and Canada, a setback for a business in which the company ...

@MassBio shared
On May 9, 2022
News Alert: We are pleased to announce a new partnership with @MorganStanley, to provide even more services and value to our members https://t.co/fdPltbp6dp
Open
MassBio® Is Pleased to Announce a New Partnership with Morgan Stanley, Providing Even More Services and Value to Its Members

MassBio® Is Pleased to Announce a New Partnership with Morgan Stanley, Providing Even More Services and Value to Its Members

May 4, 2022 (CAMBRIDGE, MA) – The Massachusetts Biotechnology Council (MassBio®) today announced that Morgan Stanley, the global financial services company, has joined its EdgeBenefits ...